BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11019851)

  • 1. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
    Gomyo H; Murayama T; Kizaki T; Mizuno I; Kitaori K; Sao H; Tobinai K; Koizumi K; Imoto S
    Bone Marrow Transplant; 2000 Sep; 26(5):577-9. PubMed ID: 11019851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia.
    Verschuur A; Brousse N; Raynal B; Brison O; Rohrlich P; Rahimy C; Vilmer E
    Bone Marrow Transplant; 1994 Sep; 14(3):467-70. PubMed ID: 7994275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation.
    Kojima K; Mannami T; Yoshino T; Kawasaki H; Sasaki K; Maeda T; Furuya K; Harada M; Hara M
    Bone Marrow Transplant; 2000 Sep; 26(5):581-3. PubMed ID: 11019852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
    Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
    Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation.
    Lyttelton MP; Browett PJ; Brenner MK; Norton JD; Kolman JL; McGee JO; Hamilton-Dutoit S; Hoffbrand AV; Prentice HG
    Bone Marrow Transplant; 1988 Nov; 3(6):641-6. PubMed ID: 2850832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH; Chiang KY; McGuirk JP; Pati AR; Godder KT; Welsh JA; Waldron RL; McElveen JL; Henslee-Downey PJ
    Bone Marrow Transplant; 1998 Feb; 21(3):295-7. PubMed ID: 9489654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
    Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
    Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.
    Bielorai B; Deeg HJ; Weintraub M; Neumann Y; Rosner E; Amariglio N; Rechavi G; Toren A
    Bone Marrow Transplant; 2003 May; 31(10):931-4. PubMed ID: 12748672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
    O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
    Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
    Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
    Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-positive B cell cerebral lymphoma 12 years after sex-mismatched kidney transplantation: post-transplant lymphoproliferative disorder or donor-derived lymphoma?
    Phelan PJ; Murphy RK; Farrell M; O'Toole O; Heffernan J; O'Brien D; Breathnach O; Conlon PJ
    Nephrol Dial Transplant; 2010 Jun; 25(6):2032-5. PubMed ID: 20348150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.